ArticleScientific reports2026
Association between lactate-to-albumin ratio and mortality in patients with sepsis-induced coagulopathy: a retrospective cohort study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to investigate the association between the lactate-to-albumin ratio (LAR) and adverse outcomes in critically ill patients with sepsis-induced coagulopathy (SIC). Clinical data from 1960 patients admitted to the Intensive Care Unit (ICU) with SIC were extracted from the MIMIC-IV (3.1) database. The study population was divided into four groups according to quartiles of LAR. The primary outcome was 28-day all-cause mortality, and the secondary outcome was ICU mortality. Kaplan-Meier curves, Cox proportional hazards regression, restricted cubic spline analyses, and subgroup analyses were used to investigate the association between LAR and adverse outcomes. Additionally, receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive ability of LAR for adverse outcomes in patients with SIC. Finally, a nomogram model was constructed using the Boruta algorithm to integrate key predictors. This study included a total of 1960 patients with SIC. The LAR was independently associated with both 28-day all-cause mortality and ICU mortality (both p < 0.01). Kaplan-Meier survival curve analysis demonstrated that patients with higher LAR levels had significantly lower 28-day and ICU survival rates (Log-rank test, p < 0.001).Restricted cubic spline (RCS) analysis indicated a linear relationship between LAR and mortality risk (overall p < 0.001; nonlinearity p = 0.068). ROC analysis showed that LAR had moderate predictive accuracy. When combined with the SOFA score, its predictive performance improved further. Building upon this, the final nomogram achieved the highest predictive accuracy for 28-day mortality. Compared with traditional scoring systems, the newly developed model demonstrated significant improvements in both reclassification and discrimination, as reflected by the Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI).Subgroup analyses revealed that this association remained consistent across all subgroups. Using Boruta to select predictive factors, a nomogram incorporating LAR was constructed, demonstrating good predictive performance for 28-day all-cause mortality (AUC 0.779, 95% CI 0.756-0.802).An online web server was built ( https://shaojian.shinyapps.io/sic-mortality-predictor/ ) to facilitate the use of the nomogram. The LAR exhibits a linear relationship with 28-day all-cause mortality and ICU mortality in SIC patients and can serve as an independent predictive factor.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.